Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RAGE Inhibitors in Neurodegenerative Diseases
V. Prakash Reddy, Puspa Aryal, Pallavi Soni
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1131-1131
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Oxidative Stress in Health and Disease
V. Prakash Reddy
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2925-2925
Open Access | Times Cited: 89
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 15
Neuroinflammaging: A Tight Line Between Normal Aging and Age-Related Neurodegenerative Disorders
Luca Soraci, Andrea Corsonello, Ersilia Paparazzo, et al.
Aging and Disease (2024)
Open Access | Times Cited: 10
Effect of advanced glycation end-products in a wide range of medical problems including COVID-19
Agnieszka Bronowicka-Szydełko, Kinga Gostomska‐Pampuch, Aleksandra Kuzan, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 1, pp. 36-50
Open Access | Times Cited: 10
Pivotal role of AGE-RAGE axis in brain aging with current interventions
Nikolaos Vitorakis, Christina Piperi
Ageing Research Reviews (2024) Vol. 100, pp. 102429-102429
Closed Access | Times Cited: 7
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
Lisa Sequeira, Sofia Benfeito, Carlos Fernandes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 708-708
Open Access | Times Cited: 5
Methylglyoxal-Induced Neuronal Dysfunction: Linking Diabetes to Alzheimer's Disease through Cytoskeletal Disruption
Majid Tozihi, Alireza Nourazarian, Hadi Yousefi, et al.
European Journal of Pharmacology (2025), pp. 177526-177526
Closed Access
Therapeutic potential of plant-derived natural compounds in Alzheimer’s disease: Targeting microglia-mediated neuroinflammation
Yanyan Shen, Fang Liu, Mingjie Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117235-117235
Closed Access | Times Cited: 4
Identification of gene expression change associated with isoflurane anesthesia and neurocognitive disorders using bioinformatics methods
Yang Liu, Ying Zhang, Jialu Yu, et al.
Journal of Pharmacological and Toxicological Methods (2025) Vol. 132, pp. 107582-107582
Closed Access
Advanced glycation end products and human diseases
Hamad Abu Zahra
Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale (2025)
Open Access
Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study
Fernando Rodrı́guez de Fonseca, Francisco Medina-Paz, Mira Sapozhnikov, et al.
Toxics (2024) Vol. 12, Iss. 3, pp. 190-190
Open Access | Times Cited: 3
Erjingwan and Alzheimer’s disease: research based on network pharmacology and experimental confirmation
Yuya Xu, Jian Zhang, Xuling Li
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Quantitative Assessment of Intracellular Effectors and Cellular Response in RAGE Activation
Vinitha Deepu, Vikrant Rai, Devendra K Agrawal
Archives of Internal Medicine Research (2024) Vol. 07, Iss. 02
Open Access | Times Cited: 2
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Jana Hroudová, Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111069-111069
Closed Access | Times Cited: 2
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Gabriela Seplovich, Yazan Bouchi, Juan Pablo de Rivero Vaccari, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 6, pp. 1644-1664
Open Access | Times Cited: 2
A Fisetin Delivery System for Neuroprotection: A Co-Amorphous Dispersion Prepared in Supercritical Carbon Dioxide
Szymon Sip, Natalia Rosiak, Anna Sip, et al.
Antioxidants (2023) Vol. 13, Iss. 1, pp. 24-24
Open Access | Times Cited: 6
Unique Bioactives from Zombie Fungus (Cordyceps) as Promising Multitargeted Neuroprotective Agents
Himadri Sharma, Niti Sharma, Seong Soo A. An
Nutrients (2023) Vol. 16, Iss. 1, pp. 102-102
Open Access | Times Cited: 6
Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis
Lingjie Zhang, Ninggang Chen, Yi Liao, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112479-112479
Open Access | Times Cited: 1
Antiglycating effects of citrus flavonoids and associated mechanisms
Yunli Xiao, Junfeng Shen, Jianfeng Zhan, et al.
Deleted Journal (2024) Vol. 13, Iss. 5, pp. 2363-2372
Open Access | Times Cited: 1
Synthesis and Structure of Novel Hybrid Compounds Containing Phthalazin-1(2H)-imine and 4,5-Dihydro-1H-imidazole Cores and Their Sulfonyl Derivatives with Potential Biological Activities
Łukasz Balewski, М. Gdaniec, Anna Hering, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11495-11495
Open Access | Times Cited: 1
Modulation of the Receptor for Advanced Glycation End Products Pathway by Natural Polyphenols: A Therapeutic Approach to Neurodegenerative Diseases
Yinghao Wei, Yanqing Zhang, Jie Sun, et al.
Food Bioscience (2024), pp. 105511-105511
Closed Access | Times Cited: 1
New Insights into the Role of SGLT-2 Inhibitors in the Prevention of Dementia
Cheng‐Hsien Hung, Li‐Yu Lu
Neurology International (2024) Vol. 16, Iss. 6, pp. 1717-1730
Open Access | Times Cited: 1
An integrated network analysis, RNA-seq and in vivo validation approaches to explore the protective mechanism of Mongolian medicine formulae Ruda-6 against indomethacin-induced gastric ulcer in rats
Feng Lan, A. Lisha, Terigele Bao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Exploring the vital role of microglial membrane receptors in Alzheimer’s disease pathogenesis: a comprehensive review
JUN-FENG ZHAO, YI-RAN JIANG, TIAN-LIN GUO, et al.
Biocell (2024) Vol. 48, Iss. 7, pp. 1011-1022
Open Access
Dynamic changes in key factors of the blood-brain barrier in early diabetic mice
Zhi-yong Xu, Shu-xian Fu, Huichao Zhao, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 9, pp. 763-771
Closed Access
Page 1 - Next Page

Scroll to top